MAPT and Alzheimer disease: Expect for imaging diagnosis tools, it has also developed the detection of cerebrospinal fluid (CSF) biomarkers, such Aβ1-40 (Aβ40), Aβ1-42 (Aβ42), and the phosphorylation of tau (p-Tau) for AD diagnosis.